PDCD1LG2 and cancer: Among the specimens of diagnostic biopsies, one sample showed 1+ (1–25%) PD-L2 staining by cancer cells and another sample 2+ (26–50%) PD-L2 staining by TILs (same results for both PD-L2 antibodies; Fig. 1a, b).